Back to Search Start Over

CYP21A2 intronic variants causing 21-hydroxylase deficiency

Authors :
Concolino, P
Rizza, Roberta
Costella, Alessandra
Carrozza, Cinzia
Zuppi, Cecilia
Capoluongo, Ettore Domenico
Rizza, R
Costella, A
Carrozza, C (ORCID:0000-0003-1045-0470)
Zuppi, C (ORCID:0000-0003-4710-4934)
Capoluongo, E. (ORCID:0000-0001-9872-0572)
Concolino, P
Rizza, Roberta
Costella, Alessandra
Carrozza, Cinzia
Zuppi, Cecilia
Capoluongo, Ettore Domenico
Rizza, R
Costella, A
Carrozza, C (ORCID:0000-0003-1045-0470)
Zuppi, C (ORCID:0000-0003-4710-4934)
Capoluongo, E. (ORCID:0000-0001-9872-0572)
Publication Year :
2017

Abstract

Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder mainly caused by defects in the steroid 21-hydroxylase gene (CYP21A2). Most of CYP21A2 mutations result from intergenic recombinations between CYP21A2 and closely linked CYP21A1P pseudogene. Rare mutations not generated by gene conversion account for 5-10% of 21-hydroxylase deficiency alleles. Intronic variants represent only a little part of these but their effect on the protein is generally deleterious. The aim of this paper is to provide a comprehensive literary review regarding all intronic CYP21A2 pathological variants reported to date. In addition, we describe three novel causing disease variants in our patients affected by the classic form of CAH: IVS4-1G > A, IVS5-8 T > A, IVS8-2A > G. In silico analysis revealed that all these substitutions affect the splicing process leading to a nonfunctional protein. Based on these results, we are able to classify them as pathological variants according to the patient's phenotype.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1105031508
Document Type :
Electronic Resource